Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: J Pharmacol Exp Ther. 2008 Jun 13;326(3):809–817. doi: 10.1124/jpet.108.141044

Figure 1.

Figure 1

Schematic of the Met TM and TA pathways and the points of inhibition of AOAA and 3-DA. Bolded metabolites have been of particular toxicological interest.